4.02
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
10.00%
45.60
|
41.46 | 57.48 | 51.50 | 46.62 |
Cost Of Revenue |
2.04%
21.73
|
21.30 | 23.82 | 22.50 | 21.18 |
Gross Profit |
18.41%
23.87
|
20.16 | 33.65 | 29.00 | 25.44 |
|
1.82%
34.49
|
35.13 | 30.67 | 33.25 | 33.96 |
Benefits Costs and Expenses |
0.66%
52.38
|
52.72 | 47.15 | 51.34 | 53.80 |
Costs And Expenses |
0.66%
52.38
|
52.72 | 47.15 | 51.34 | 53.80 |
Operating Income/Loss |
29.06%
-10.62
|
-14.97 | 2.986 | -4.248 | -8.527 |
Nonoperating Income/Loss |
3.77%
3.849
|
3.709 | 7.337 | 4.405 | 1.341 |
Income/Loss From Continuing Operations Before Tax |
39.86%
-6.775
|
-11.27 | 10.32 | 0.157 | -7.186 |
Income Tax Expense/Benefit, Deferred |
511.90%
-2.056
|
-0.336 | - | - | - |
Income Tax Expense/Benefit |
976.47%
-1.192
|
0.136 | 0.68 | -0.784 | 3.248 |
Income/Loss From Continuing Operations After Tax |
51.03%
-5.583
|
-11.40 | 9.643 | 0.941 | -10.43 |
|
51.03%
-5.583
|
-11.40 | 9.643 | 0.941 | -10.43 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.09%
126.93
|
128.34 | -0.51 | 131.00 | 131.44 |
Diluted Average Shares |
1.09%
126.93
|
128.34 | -0.51 | 132.79 | 131.44 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):